20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
Seven big projects with international pharmaceutical companies were completed. Two research papers co-authored with colleagues from other organizations were published in PLOS Computational Biology and CPT: Pharmacometrics & Systems Pharmacology.
ISBM took part in 2 exhibitions and 4 important conferences, the employees presented their reports and posters on The International Liver Congress 2016, Population Approach Group in Europe 2016 Meeting (PAGE 2016), American Society for Clinical Pharmacology and Therapeutics 2016 Meeting (ASCPT 2016) and 6th American Conference on Pharmacometrics (ACoP6). And ISBM CEO, Oleg Demin, won the Quality Award for his oral presentation at the ACoP6.
We released an updated version of the Immune Response Template (IRT), a platform for Quantitative Systems Pharmacology modeling in the immune oncology field. It’s a big step for further QSP platform solutions development.
A new working year starts from the very important event – ASCPT 2017 Meeting. ISBM presents 8 posters and the IRT stand at the Exhibition. We will write about it in more details soon.
← | August 2023 | → | ||||
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1
|
2
|
3
|
4
|
5
|
6
| |
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
1.
16 Aug 2023 16:51
InSysBio to participate in World Bispecific Summit 2023
InSysBio announces its participation in the 14th Annual World Bispecific Summit which is to be held on October 2-4, 2023 at Boston Park Plaza, Boston, MA. Oleg Demin Jr, Scientific Director, QSP modeling in Oncology & Immuno-Oncology, InSysBio will give a talk within its frames
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|